Urology · Smithtown, NY
NPI
1447348115
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
363 Route 111, Suite 107
Smithtown, NY, 11787
Phone (631) 360-7450
Groups this clinician bills Medicare through
Medicare paid, 2024
$501K
22,866 services
Medicare patients, 2024
1,604
Average age 76
Drug cost, 2024
$1.0M
3,329 prescriptions
Company payments, 2025
$826
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas G Harrington was code J1071 (injection, testosterone cypionate, 1 mg), 10,050 times for 15 patients. In total Thomas G Harrington billed 22,866 services in 110 codes, and Medicare paid $501K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 10,050 | 15 | $0.00 | $0.53 |
| 81003 Clinical Chemistry | Office | 2,203 | 1,323 | $2.19 | $4,834 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,905 | 1,261 | $14.71 | $28K |
| 99214 Office E&M - Established | Office | 1,104 | 783 | $116.92 | $129K |
| 99213 Office E&M - Established | Office | 709 | 576 | $77.43 | $55K |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 590 | 14 | $2.67 | $1,577 |
| 36415 Venipuncture Blood Collection | Office | 511 | 399 | $8.62 | $4,403 |
| 84153 Clinical Chemistry | Office | 430 | 349 | $18.02 | $7,749 |
| J0278 Injection, amikacin sulfate, 100 mg | Office | 233 | 19 | $0.64 | $149 |
| 87086 Bacterial Culture | Office | 206 | 163 | $7.91 | $1,629 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 187 | 29 | $135.72 | $25K |
| 99212 Office E&M - Established | Office | 186 | 174 | $51.02 | $9,489 |
| 51798 Ultrasound - Nonspecific | Office | 162 | 104 | $11.30 | $1,831 |
| 52000 Cystourethroscopy | Office | 156 | 127 | $234.38 | $37K |
| 96402 Chemotherapy Administration | Office | 139 | 29 | $34.76 | $4,831 |
By year: 2022 $369K for 15,873 services; 2023 $434K for 22,147 services; 2024 $501K for 22,866 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 2,203 | 1,323 | $2.19 | $4,834 |
| 36415 Venipuncture Blood Collection | 511 | 399 | $8.62 | $4,403 |
| 84153 Clinical Chemistry | 430 | 349 | $18.02 | $7,749 |
| 87086 Bacterial Culture | 206 | 163 | $7.91 | $1,629 |
| 87186 General Laboratory | 101 | 46 | $8.48 | $856 |
| 84154 Clinical Chemistry | 83 | 65 | $18.02 | $1,496 |
| 87088 Bacterial Culture | 60 | 46 | $7.93 | $476 |
| 87077 Bacterial Culture | 58 | 45 | $7.92 | $459 |
| 80053 Clinical Chemistry | 22 | 18 | $10.35 | $228 |
| 80048 Clinical Chemistry | 16 | 15 | $8.29 | $133 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas G Harrington prescribed most often to Medicare patients was Tamsulosin Hcl, with 869 prescriptions and refills. In total Thomas G Harrington wrote 3,329 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 869 | 2,483 | 293 | $17K |
| Finasteride Generic | 509 | 1,502 | 169 | $7,276 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 237 | 585 | 81 | $3,889 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 149 | 149 | 118 | $923 |
| Gemtesa Vibegron | 131 | 261 | 39 | $123K |
| Doxazosin Mesylate Generic | 127 | 344 | 38 | $2,774 |
| Allopurinol Generic | 116 | 319 | 42 | $1,337 |
| Cephalexin Generic | 97 | 209 | 55 | $2,236 |
| Ciprofloxacin Hcl Generic | 79 | 79 | 61 | $416 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 69 | 196 | 37 | $3,420 |
| Potassium Citrate Er Potassium Citrate | 68 | 151 | 19 | $6,111 |
| Solifenacin Succinate Generic | 62 | 132 | 21 | $4,619 |
| Myrbetriq Mirabegron | 59 | 124 | 27 | $55K |
| Tadalafil Generic | 57 | 125 | 15 | $4,069 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 52 | 68 | 44 | $170 |
Brand drugs: 324 claims; generic drugs: 3,005 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas G Harrington $826 ($826 in general payments such as food, travel and fees) from 16 companies. The largest payer was Sumitomo Pharma America, Inc. with $177.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 8 | $177 |
| Pfizer Inc. PFE | 4 | $102 |
| Olympus America Inc. | 4 | $95.34 |
| Endo USA, Inc. | 4 | $71.08 |
| Janssen Biotech, Inc. JNJ | 2 | $55.29 |
| Dendreon Pharmaceuticals LLC | 2 | $45.89 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $44.51 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $35.06 |
| Progenics Pharmaceuticals, Inc. | 1 | $29.32 |
| Immunitybio, Inc. IBRX | 1 | $28.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.